Drug Development

Articles

Formulation issues cause significant drug project delays and project failures, according to a 2018 survey conducted by Informa Pharma Intelligence, Rentschler Biopharma, and LEUKOCARE.

Survey Predicts Drug Product Formulation Recognition and Increasing Budgets

AbbVie will grant Momenta license to launch a biosimilar to AbbVie’s Humira.

AbbVie Signs Patent License with Momenta for Humira Biosimilar

Researchers evaluated the chemical stability of two different naloxone products administered to prevent opioid overdose deaths and found the products to have a significantly extended shelf life than previously known.

Opioid Overdose Reversal Products are Chemically Stable Well Past Expiration Date, Says Study

Irish manufacturer of generic medicines for both human and animal health, Chanelle Pharma, has been named as Pharma Industry Company of the Year 2018.

Chanelle Pharma Named as Pharma Industry Company of the Year 2018

The company received FDA approval for Hyrimoz (adalimumab-adaz), its biosimilar referencing AbbVie’s blockbuster Humira (adalimumab).

Sandoz Gets FDA Approval for Humira Biosimilar

As biologic drugs grow increasingly complex, drug delivery mechanisms such as prefilled syringes are being adapted to meet the challenges.

Innovations in Prefilled Syringes for Biologic Drugs

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Demand for highly potent APIs continues to rise.

Building Capacity for Potent API Production

he acquisition expands the company’s formulation and analytical R&D services.

Velesco Pharma Acquires New R&D and cGMP Analytical Lab

The companies announced the European launch of Imraldi (adalimumab), a biosimilar referencing AbbVie’s blockbuster Humira (adalimumab).

Biogen and Samsung Bioepis Launch Humira Biosimilar in Europe

Mylan announced the launch of its biosimilar to AbbVie’s Humira across major European markets.

Formulation and Drug Delivery